The Global Program Manager, ITO is responsible for leading strategic, cross-functional transformation programs across the Infrastructure & Technology Operations portfolio. The role serves as a key member of the Strategic Program Office, partnering with technology leaders, service owners, architecture teams, vendors and business stakeholders to drive successful planning and execution of large-scale initiatives.
The position provides end-to-end program leadership, portfolio governance, executive reporting, financial oversight, dependency management and risk management for strategic initiatives spanning Cloud, Data Center, Hosting, Connectivity, Workplace and Technology Operations. The role ensures alignment of program outcomes with Sandoz Technology strategy and delivery objectives while driving value realization across the organization.
Why Sandoz?
Sandoz is the global leader in Biosimilar and Generic medicines, a segment of the healthcare industry that delivers 80% of the world’s medicines at 30% of the cost, touching the lives of more than 1 billion people across 100+ countries! While we are proud of our achievements, we have an ambition to do more so that everyone can achieve the basic human right of good health.
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help even more people gain access to low-cost, high-quality medicines, sustainably.
Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues, who, in return for applying their skills, experience an agile and collegiate environment with impactful careers, where diversity of thought is welcomed and where personal growth is supported!
Join us, help us make healthcare fairer and faster.
We are committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
#Sandoz

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc